scispace - formally typeset
L

Lorenzo Rivas-García

Researcher at University of Granada

Publications -  28
Citations -  416

Lorenzo Rivas-García is an academic researcher from University of Granada. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 7, co-authored 21 publications receiving 176 citations. Previous affiliations of Lorenzo Rivas-García include Universidade Nova de Lisboa.

Papers
More filters
Journal ArticleDOI

Gene Therapy in Cancer Treatment: Why Go Nano?

Catarina Roma-Rodrigues, +3 more
- 05 Mar 2020 - 
TL;DR: The current trends on the use of nanoparticles designed for cancer gene therapy, including inorganic, organic, or biological variants, in clinical development and their progress towards clinical applications are reviewed.
Journal ArticleDOI

Do nutrients and other bioactive molecules from foods have anything to say in the treatment against COVID-19?

José L. Quiles, +6 more
- 01 Dec 2020 - 
TL;DR: Options to follow through the use of substances of food origin against COVID-19 should show certain effects, such as restoring mitochondrial function and cellular redox balance, to allow reducing the susceptibility of risk groups and the cascade of events after SARS-CoV-2 infection.
Journal ArticleDOI

Are by-products from beeswax recycling process a new promising source of bioactive compounds with biomedical properties?

Francesca Giampieri, +19 more
- 01 Feb 2018 - 
TL;DR: It is shown for the first time that by-products from beeswax recycling process can represent a rich source of phytochemicals with high total antioxidant capacity and anticancer activity; however, further researches are necessary to evaluate their potentiality for human health by in vivo studies.
Journal ArticleDOI

Role of flavonoids against adriamycin toxicity.

María D. Navarro-Hortal, +7 more
- 17 Oct 2020 - 
TL;DR: This review embraces the role of flavonoids on DOX treatment side effects and reports that some of them increased DOX efficiency as anti-cancer drug even in multidrug resistant cells.
Journal ArticleDOI

Tackling Multidrug Resistance in Streptococci - From Novel Biotherapeutic Strategies to Nanomedicines.

Cinthia Alves-Barroco, +4 more
- 06 Oct 2020 - 
TL;DR: A synopsis of mechanisms associated to drug resistance in (pyogenic) streptococci is presented and some innovative strategies as alternative to conventional antibiotics, such as bacteriocins, bacteriophage, and phage lysins, and metal nanoparticles are discussed.